These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1651161)

  • 41. Optimal therapy for reduction of lipoprotein(a).
    Lippi G; Targher G
    J Clin Pharm Ther; 2012 Feb; 37(1):1-3. PubMed ID: 22276844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein(a): from molecules to therapeutics.
    Bermúdez V; Arráiz N; Aparicio D; Rojas E; Gotera D; Guerra X; Canelón R; Faría J; Sorell L; Amell A; Reyna N; Cabrera M; Mengual E; Cano R; Cano C; Velasco M
    Am J Ther; 2010; 17(3):263-73. PubMed ID: 20479580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the effectiveness of hypolipidemic preparations in coronary arteriosclerosis].
    Bobkova VI; Lokshina LI; Sidakova MM; Tananova GV; Fomchenkov SI
    Kardiologiia; 1984 Sep; 24(9):54-7. PubMed ID: 6521249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein apheresis: state of the art and novelties.
    Stefanutti C; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):19-27. PubMed ID: 23357136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lipoprotein Lp(a) as a risk factor for heart infarct--a family study].
    Klein G; Brugger P; Kullich W; Marth E; Kostner GM
    Wien Med Wochenschr; 1984 Sep; 134(18):403-8. PubMed ID: 6239458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic hyperlipidemia and atherosclerosis.
    Stone NJ
    Artery; 1979 May; 5(5):377-97. PubMed ID: 262162
    [No Abstract]   [Full Text] [Related]  

  • 47. Lipoprotein(a)--An independent causal risk factor for cardiovascular disease and current therapeutic options.
    Kassner U; Schlabs T; Rosada A; Steinhagen-Thiessen E
    Atheroscler Suppl; 2015 May; 18():263-7. PubMed ID: 25936335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Disorders of lipoprotein metabolism. I. The physiopathology].
    Ahumada Ayala M
    Arch Inst Cardiol Mex; 1991; 61(1):79-91. PubMed ID: 1646588
    [No Abstract]   [Full Text] [Related]  

  • 49. [Lipid metabolism in atherogenesis].
    Bobková D; Poledne R
    Cesk Fysiol; 2003 Feb; 52(1):34-41. PubMed ID: 12693188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hyperlipoproteinemia: epidemiology, pathogenesis, clinical symptoms, significance for the pathogenesis of arteriosclerosis].
    Haller H
    Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):640-5. PubMed ID: 7434801
    [No Abstract]   [Full Text] [Related]  

  • 51. [Do very low density lipoproteins (VLDL) participate in atherogenesis?].
    Cybulska B
    Kardiol Pol; 1992 Aug; 37(8):104-7. PubMed ID: 1434325
    [No Abstract]   [Full Text] [Related]  

  • 52. Physiological and clinical importance of lipoprotein(a).
    Romics L; Karádi I; Császár A; Kostner GM
    Tokai J Exp Clin Med; 1990 May; 15(2-3):149-54. PubMed ID: 2151833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.
    Hohenstein B; Julius U; Lansberg P; Jaeger B; Mellwig KP; Weiss N; Graehlert X; Roeder I; Ramlow W
    Atheroscler Suppl; 2017 Nov; 30():180-186. PubMed ID: 29096835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lipoprotein (a)--a mysterious factor in atherogenesis].
    Jelaković B; Laganović M; Kuzmanić D
    Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperlipoproteinemia in the production of atherosclerosis. Risk factors: diagnosis and treatment].
    Pedraza A
    Rev Fac Cien Med Univ Nac Cordoba; 1993; 51(1):21-33. PubMed ID: 7809452
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin.
    Hunt CE; Duncan LA
    Br J Exp Pathol; 1985 Feb; 66(1):35-46. PubMed ID: 3970829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent aspects of diagnosis and treatment of lipoprotein disorders. Impact on prevention of atherosclerotic diseases. Proceedings of an international symposium. Vienna, August 21-23, 1986.
    Prog Clin Biol Res; 1988; 255():1-383. PubMed ID: 3340633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.